ORA - Oxford University Research Archive

1 - 13 of 13

1

Journal article

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst, DP, Boeck, A, Freedland, SJ, et al.
2014-02-05

2

Journal article

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst, DP, Boeck, A, Freedland, SJ, et al.
2012-04-05

3

Journal article

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.

Steuber, T, Vickers, AJ, Haese, A, et al.
2006-03-05

4

Journal article

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Roobol, MJ, Schröder, FH, Hugosson, J, et al.
2012-04-05

5

Journal article

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.

Vickers, AJ, Cronin, AM, Roobol, MJ, et al.
2010-09-05

6

Journal article

Nomogram for survival analysis in the presence of competing risks

Zhang, Z, Geskus, RB, Kattan, MW, et al.
2017-10-01

7

Journal article

Systematic review of statistical methods used in molecular marker studies in cancer.

Vickers, AJ, Jang, K, Sargent, D, et al.
2008-04-05

8

Journal article

Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.

Erdamar, S, Yang, G, Harper, JW, et al.
1999-08-05

9

Journal article

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.

Steuber, T, Niemela, P, Haese, A, et al.
2005-04-05

10

Journal article

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

Steuber, T, Vickers, A, Haese, A, et al.
2007-04-05

11

Journal article

Testosterone as a predictor of pathological stage in clinically localized prostate cancer.

Isom-Batz, G, Bianco, FJ, Kattan, MW, et al.
2005-06-05

12

Journal article

Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.

Stephenson, AJ, Kattan, MW, Eastham, JA, et al.
2006-08-05

13

Journal article

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.

Haese, A, Vaisanen, V, Lilja, H, et al.
2005-03-05

TO TOP